pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,561 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    micvotabart pelidotin
    micvotabart pelidotin [INN]
    Human Epidermal Growth Factor Receptor 2 Negative Breast…$PYXS Pyxis Oncology, Inc.
  • Phase 2
    mifomelatide
    mifomelatide [INN]
    Cancer Anorexia-Cachexia Syndrome Kalohexis LLC
  • Phase 2
    milrinone ER
    milrinone
    Congestive Heart Failure (Heart Failure) Hyloris Pharmaceuticals SA
  • Phase 2
← prev
page 43 of 53
next →
131
Pain89
Neurology1
mipletamig
mipletamig [INN]
Refractory Acute Myeloid Leukemia
$APVO Aptevo Therapeutics Inc.
  • Phase 2
    miransertib mesylate
    miransertib mesylate
    Proteus Syndrome$MRK Merck & Co., Inc.
  • Phase 2
    mirdametinib
    Gomekli (mirdametinib)
    Non-Small Cell Lung Cancer SpringWorks Therapeutics Inc
  • Phase 2
    misoprostol
    Misoprostol Greenstone (misoprostol)
    Labor And Delivery AFYX Therapeutics A/S
  • Phase 2
    mitazalimab
    mitazalimab [INN]
    Pancreatic Ductal Adenocarcinoma Alligator Bioscience AB
  • Phase 2
    mitolactol
    mitolactol [INN]
    Glioblastoma Multiforme (GBM) Eleison Pharmaceuticals Inc
  • Phase 2
    mocaciclib
    mocaciclib [INN]
    Endometrial Cancer Qurient Co Ltd
  • Phase 2
    mometasone furoate
    Sinuva (mometasone furoate)
    Eosinophilic Esophagitis EsoCap AG
  • Phase 2
    monlunabant
    monlunabant [INN]
    Diabetic Nephropathy Inversago Pharma Inc
  • Phase 2
    mosedipimod
    mosedipimod
    Coronavirus Disease 2019 (COVID-19) Associated Acute Resp… Enzychem Lifesciences Corp
  • Phase 2
    moxidectin
    Moxidectin
    Scabies Atticus Medical Pty Ltd
  • Phase 2
    mozistobart zoratolimod
    mozistobart zoratolimod [INN]
    Bile Duct Cancer (Cholangiocarcinoma) Tallac Therapeutics Inc
  • Phase 2
    mupadolimab
    mupadolimab
    Non-Small Cell Lung Cancer$CRVS Corvus Pharmaceuticals, Inc.
  • Phase 2
    muzastotug
    muzastotug [INN]
    Solid Tumor$ADAG Adagene Inc.
  • Phase 2
    nLLMNB1-001
    Leukodystrophies n-Lorem Foundation
  • Phase 2
    nLTUBB4-001
    Leukodystrophies n-Lorem Foundation
  • Phase 2
    narmafotinib tartrate
    narmafotinib tartrate
    Metastatic Adenocarcinoma of The Pancreas Amplia Therapeutics Ltd
  • Phase 2
    naronapride
    naronapride
    Diabetic Gastroparesis Renexxion LLC
  • Phase 2
    navicixizumab
    navicixizumab
    Fallopian Tube Cancer Feng Biosciences Inc
  • Phase 2
    navtemadlin
    navtemadlin
    Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis) Kartos Therapeutics Inc
  • Phase 2
    naxitamab
    Danyelza (naxitamab-gqgk)
    Neuroblastoma Y-mAbs Therapeutics Inc
  • Phase 2
    nebokitug
    nebokitug
    Primary Sclerosing Cholangitis$CMMB Chemomab Therapeutics Ltd.
  • Phase 2
    nedometinib
    nedometinib
    Neurofibromatoses Type I (Von Recklinghausen's Disease) NFlection Therapeutics Inc
  • Phase 2
    neflamapimod
    neflamapimod
    Frontotemporal Dementia (Pick Disease)$CRVO CervoMed Inc.
  • Phase 2
    nemolizumab
    Nemluvio (nemolizumab)
    Systemic Sclerosis (Scleroderma) Galderma SA
  • Phase 2
    nemonoxacin
    Taigexyn (nemonoxacin [INN])
    Diabetic Foot Infection (DFI) TaiGen Biotechnology Co Ltd
  • Phase 2
    nemtabrutinib
    nemtabrutinib
    Follicular Lymphoma$MRK Merck & Co., Inc.